Abstract

Raman spectroscopy can be used as a tool to study virus entry and pathogen-driven manipulation of the host efficiently. To date, Epstein–Barr virus (EBV) entry and altered biochemistry of the glial cell upon infection are elusive. In this study, we detected biomolecular changes in human glial cells, namely, HMC-3 (microglia) and U-87 MG (astrocytes), at two variable cellular locations (nucleus and periphery) by Raman spectroscopy post-EBV infection at different time points. Two possible phenomena, one attributed to the response of the cell to viral attachment and invasion and the other involved in duplication of the virus followed by egress from the host cell, are investigated. These changes corresponded to unique Raman spectra associated with specific biomolecules in the infected and the uninfected cells. The Raman signals from the nucleus and periphery of the cell also varied, indicating differential biochemistry and signaling processes involved in infection progression at these locations. Molecules such as cholesterol, glucose, hyaluronan, phenylalanine, phosphoinositide, etc. are associated with the alterations in the cellular biochemical homeostasis. These molecules are mainly responsible for cellular processes such as lipid transport, cell proliferation, differentiation, and apoptosis in the cells. Raman signatures of these molecules at distinct time points of infection indicated their periodic involvement, depending on the stage of virus infection. Therefore, it is possible to discern the details of variability in EBV infection progression in glial cells at the biomolecular level using time-dependent in vitro Raman scattering.
Introduction
Raman spectroscopy (RS) is a sensitive enough tool to capture the characteristic bond vibrations of molecules and elucidate minute biochemical changes occurring in complex biological systems such as cells, tissue, and other body fluids.1 Notably, any alteration in the biochemical homeostasis of the body may inevitably be associated with a disease state, mark disease initiation, or represent the aftermath of an illness.2 For instance, biochemical changes due to manipulation in the carbohydrate metabolism may cause various pathological conditions such as galactosemia, diabetes, diabetic ketoacidosis, hyperglycemia, hereditary fructose intolerance, and glycogen storage disorders.3 Besides, conditions like phenylketonuria, tyrosinemia, maple syrup urine syndrome, etc. appear due to alterations in the protein expression.4 Additionally, alterations in lipid metabolism may lead to conditions such as familial hypercholesterolemia, hypertriglyceridemia, and low high-density lipoprotein (HDL).5 RS is used to analyze human serum samples for various biochemical components such as glucose, cholesterol, lipids,6 phenylalanine,7 etc. for the detection of respective metabolic disorders mentioned above. The use of RS has been so far extended as a diabetes management tool to determine the blood glucose level subcutaneously.8 Thus, the technique presents an immense potential in the field of disease diagnosis. Also, it is widely utilized to understand cancer, infection, and inflammation in the human body.1 RS can differentiate between invasive and noninvasive breast cancer based on Raman spectral markers.9 It is also employed to detect inflammation in the colon of patients suffering from inflammatory bowel disease (IBD),10 in in vitro Tumor necrosis factor or TNF-α (pro-inflammatory cytokine)-treated endothelial cells,11 and in in vivo experiments on tympanic membrane of a murine model.12 Signature Raman spectra arising from lipids, collagen, or DNA content of the respective samples identified the disease-associated alterations. Infections with similar clinical symptoms like dengue and malaria can easily be distinguished using RS based on differentially regulated metabolites.13
Moreover, the technique is used to study various virus-associated modalities of Kaposi’s sarcoma-associated herpesvirus (KSHV) infection in BCBL-1, BC-1, and BJAB (B-cell lineage)14 and rotavirus15 and human papillomavirus (HPV) infection in primary human keratinocytes (PHKs) and CaSki cells.9 In the last few decades, the prevalence of ubiquitous herpesviruses has accounted for a major disease burden in the human population worldwide.16 Human herpesvirus-4 (HHV-4) also known as Epstein–Barr virus (EBV) is an important member of the Herpesviridae family. It infects about 90% of the world population.17 Primary infection during childhood largely remains asymptomatic; however, infection in adults could cause infectious mononucleosis (IM).18 Moreover, reactivation of the virus later in life after the initial exposure has been linked to serious conditions such as IM-like disease, hemophagocytic syndrome, chronic active EBV infection, and lymphomas.19 It is also a recognized oncogenic virus known to infect lymphocytes and cause B-cell lymphomas (Burkitt’s and Hodgkin’s lymphoma) or lymphoproliferative disorders. EBV can infect epithelial cells resulting in nasopharyngeal carcinoma or EBV-associated gastric cancer.20 Interestingly, the presence of EBV transcripts and DNA in the cerebrospinal fluid (CSF) of patients with neurodegenerative disorders such as Alzheimer’s disease (AD),21 Parkinson’s disease (PD),22 multiple sclerosis (MS),23 etc. provides clues toward the possibility of EBV infecting the brain cells (neurons and glial cells).
In general, to successfully infect any cell a virus must first attach to its surface and then penetrate through the outer cell membrane to insert its genomic content inside the cell. The entry of the virus inside a cell essentially depends upon the interaction between the virus surface proteins and the host cell receptors. It, therefore, limits the virus infectivity to host cells possessing the receptor and thereby defines its cell tropism.24 Nonetheless, several recent studies have shown the plausibility of viruses such as SARS-CoV225 and Zika26 virus to infect cells of multiple origins, i.e., exhibiting the property of multitropism. Studies demonstrated that EBV shows the property of multitropism by infecting B-cells, epithelial cells, and possibly neural cells as well.27 EBV infects B-cells with the help of interaction between gp350, a glycoprotein present on its surface, and CD-21 surface marker expressed on the host cells.28 However, EBV attaches and enters inside the epithelial cells in a CD-21-independent manner. The predicted cell receptors that may facilitate EBV entry inside the epithelial cells via gHgL (a viral glycoprotein) include integrin and ephrin molecules.29 Fascinatingly, Jha et al. for the first time characterized in vitro EBV infection in a neuroblastoma cell line (ShSy-5y), teratocarcinoma neurons (Ntera2), and primary human fetal neurons.29 Further, we successfully demonstrated EBV infection in glial cells, namely, HMC-3 (microglia) and U-87 MG (astroglia).
Moreover, the virus may take advantage of diverse pathways in cells of different origins to gain entry and carry out its replication.30 The type of genetic material (RNA or DNA) of the virus decides further processing, which is accompanied by major alterations in the biochemistry of the host cell. Briefly, these processes involve viral genome replication, transcription, and translation. This disparity in biomolecular pathways adopted by the virus in different cells may alter the kinetics of infection,31 the duration of time elapsed from attachment to gaining entry, and further carrying out of the replication.32 For instance, in B-cells, postinfection transcriptional changes are detected within the first 24 h preceding metabolic and phenotypic changes. EBV-initiated transcriptional reprogramming in B-cells is broadly categorized under three stages: RNA synthesis, manipulation of metabolic pathways, followed by cell division that occurs subsequently on the second, third, and fourth days post infection (dpi), respectively.33 In contrast, de novo (cell-in-cell) EBV infection in epithelial cells is initiated as early as 4 h post infection (hpi), and activation of EBV can be traced by 6 hpi. In SHSy-5y and Ntera2 cells, the infection could be detected by 1 dpi and proceed to the lytic cycle by 9 dpi.29 Therefore, the same virus may take different time durations to establish a successful infection in cells of different origins.
Therefore, we investigated the biomolecular changes in the glial cells upon EBV infection at different time intervals using RS. We intended to identify the unique Raman signals originating from the EBV invasion and infection in the glial cells, in particular astrocytes and microglia. Also, in our study, we observed differential regulation of various biochemical molecules in the cell body (periphery) and the nucleus. These modulations in the biomolecules also led to alterations in the signaling pathways associated with them. The temporal (infection progression with time) and spatial (infection condition at different locations on the cell) Raman analysis provides a consolidated study on the dynamics of EBV infection.
Results
Raman Spectra
We observed different peaks for HMC-3 and U-87 MG, pre- and postinfection, on plotting the raw data points (wavenumber vs intensity) of the Raman spectra using Origin-2018b software at various time durations (2, 4, 6, 12, 24, 36, and 48 h). For HMC-3, five major Raman peaks were observed in the wavenumber ranges of 547–560, 1097–1109, 2047–2054, 2669–2676, and 3825–3840 cm–1 in the nucleus (Figure 1A-I,II), whereas at the periphery, five peaks were documented in the ranges of 548–554, 1097–1125, 2043–2051, 2673–2679, and 3828–3843 cm–1 (Figure 1B-I,II). For U-87 MG, five major Raman peaks in the nucleus were observed in the ranges of 472–494, 999–1005, 1442–1450, 1655–1664, and 2879–2890 cm–1 (Figure 1C-I,II). Three major peaks corresponding to the ranges of 472–483, 998–1004, and 2872–2892 cm–1 were obtained at the peripheral region of U-87 MG (Figure 1D-I,II).
Figure 1.
Raman spectra acquired from (A) the nucleus of HMC-3 [(I) and (II)], (B) the periphery of HMC-3 [(I) and (II)], (C) the nucleus of U-87 MG [(I) and (II)], and (D) the periphery of U-87 MG [(I) and (II)]. The Raman spectra were acquired in the wavenumber range from 400 to 3500 cm–1 for HMC-3 and from 400 to 4000 cm–1 for U-87 MG cells. A 633 nm laser excitation source was used to record the data.
For ease of further processing and validating the number of major peaks, the dimensionality of the raw data was reduced using principal component analysis (PCA). We obtained probable solutions, i.e., the principal components in our data in the range of 3–8, thus validating the number of peaks observed in the graph.
Biomolecules’ Peak Identification in Glial Cells
The distinct peaks that we obtained from the graph correspond to the signature spectra of unique biomolecules (Table 1). On comparing the Raman signals of these molecules in the infected samples with those of the uninfected (UI) ones, we observed variations in vibrational intensity at different time points. The positive variation, i.e., upregulation of intensity above the basal level of uninfected cells, represented an increase in the number of molecules probably due to their enhanced anabolic activity. Also, a decline of signal intensity of the molecule below the basal levels depicted a decrease in the number of molecules due to their consumption/catabolism.
Table 1. Signature Raman Spectral Range of Biomolecules Reported to Be Associated with Viral Infectiona,b.
| wavenumber range (cm–1) | wavenumber (cm–1) | associated Biomolecule | probable function in cell metabolism | reports on association with virus infection |
|---|---|---|---|---|
| 460–480 | 481 | DNA | genetic material | |
| 484–490 | glycogen | energy-storage molecule | 1. HCMV enhances glycolytic flux to fuel fatty acid synthesis111 | |
| 2. HSV-1 gears glycolytic metabolism toward the production of pyrimidine nucleotide components111 | ||||
| 3. EBV-infected NPC cell lines show increased glycolysis levels; LMP-1 of EBV induces hexokinase-2 to induce glycolysis and upregulation of GLUT-1120 | ||||
| 540–560 | 548 | cholesterol/cholesterol esters | cell membrane constituent (maintains membrane fluidity), involved in cell signaling, transport processes, and nerve conduction | 1. cellular cholesterol facilitates the postentry replication cycle of herpes simplex virus-1102 |
| 2. a nuclear receptor involved in cholesterol metabolism regulates herpesvirus latency and reactivation121 | ||||
| 3. EBV: LMP-2A is secreted in exosomes in a cholesterol-dependent manner122 | ||||
| 4. KSHV: decreased cholesterol synthesis123 | ||||
| 540 | glucose-saccharide band | energy currency of the cell | 1. HBV: increased gluconeogenesis and glycolysis124 | |
| 573 | tryptophan | essential amino acid, involved in synthesis of brain serotonin and kynurenine | 1. conserved tryptophan motifs in the large tegument protein pUL36 are required for efficient secondary envelopment of herpes simplex virus capsids125 | |
| 2. indoleamine-2,3-dioxygenase (IDO) plays a role in IFN-γ-mediated antiviral effects against HSV infections126 | ||||
| 776–800 | 776 | phosphatidylinositol | interacts with proteins, involved in cell signaling cascades, and intracellular membrane trafficking; primary source of arachidonic acid (in brain) | 1. KSHV induces PI-3K/AKT/mTOR pathway to facilitate its survival and proliferation in B-cells92 |
| 2. inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances γ-2 herpesvirus (HHV-8/KSHV) lytic replication and facilitates reactivation from latency127 | ||||
| 782 | thymine/cytosine, guanine | basic unit of genetic material, molecules like ATP, NADH, etc. | ||
| 784 | phosphodiester, cytosine | components of the genetic material (forming backbone of DNA/RNA) | ||
| 786 | pyrimidine ring | |||
| 787 | phosphatidylserine | |||
| 788 | O–P–O stretching DNA | |||
| 850–855 | 852 | proline/hydroxyproline, tyrosine | involved in cell signaling pathways regulating cell proliferation and mTOR pathway; can scavenge ROS | |
| 852 | glycogen | energy-storage molecule | ||
| 1112–1124 | 1117 | glucose and saccharide band | energy currency of the cell | |
| 1122 | polysaccharides | energy storage or structural support | ||
| 1124 | C–C stretching mode of lipids | conformational structure of lipids; involved in long-term energy storage, cell membrane constitution, and intercellular transmembrane transport | 1. HCMV: increased lipid biosynthesis128 | |
| 2. KSHV; increased lipid synthesis129 | ||||
| 1257–1263 | 1258–60 | amide III | structural constituent of proteins in the body | 1. HCMV: increased anaplerotic use of glutamine130 |
| 1260 | protein band | plays multiple roles in the cells; involved in cell signaling, proliferation, etc.; structural role | ||
| second amide | ||||
| 1270–1280 | 1264 | triglycerides | main component of dietary fats, act as long-term energy-storage molecules | 1. HSV, EBV, and CMV: infection facilitates cytokine-induced alterations in lipid and lipoprotein metabolism, leading to decreased serum levels of total cholesterol (TC), HDL-C, LDL-C, apoA1, apoB, and Lp(a), as well as increased triglyceride (TG) and apoE concentrations131 |
| 1270 | unsaturated fatty acids | 1. DENV: increased fatty acid biosynthesis132 | ||
| 1270 | phospholipids | |||
| 2860–2880 | 2853–2881 | lipids and proteins | structural constitution of the cell; involved in signaling and transport | 1. vaccinia virus: increased de novo fatty acid biosynthesis and β-oxidation133 |
| 2. HBV: disturbed lipid synthesis134 | ||||
| 3. HCV: decreased lipid secretion135 |
The table enlists the specific Raman signature of the biomolecules that are known to be altered on infection with different viruses and how the virus utilizes them.
HCMV, human cytomegalovirus; HSV-1, herpes simplex virus-1; EBV, Epstein–Barr virus; KSHV, Kaposi’s sarcoma-associated herpesvirus; HBV, hepatitis B virus; and DENV, dengue virus.
Specifically, upon EBV infection in the microglial cells, we observed the highest activity of DNA and glycogen (481–495 cm–1) molecules at 2 and 12 hpi in the nucleus (Figure 2A-1(I)), while no signals are obtained from the periphery (Figure 2A-1(II)). The intensities have been used with respect to the control (uninfected) samples; negative values imply the decrease in intensity with respect to the control sample. The signals associated with cholesterol and cholesterol esters (548–560 cm–1)35,36 were elevated at 2 and 12 hpi in the nucleus, depicting their maximum anabolic activity at these time points (Figure 2A-2(I)), whereas on the periphery, their activity appeared to be highest at 2, 6, and 36 hpi (Figure 2A-2(II)). Similarly, the maximum amount of phosphatidylinositol (PIP), uracil, and phosphodiester group (740–790 cm–1)36−38 was noted at 2, 4 and 12 hpi in the nucleus (Figure 2A-3(I)) and at 2, 6, and 36 hpi on the periphery (Figure 2A-3(II)). The Raman signals depicted the highest amount of polysaccharide, proline, and valine molecules (939–952 cm–1)39,40 in the nucleus at 24 hpi. Additionally, we observed maximum consumption of these molecules in the nucleus at 6 hpi denoted by reduced signals (Figure 2A-4(I)), and their maximum expression levels on the periphery appear at 4 and 24 hpi (Figure 2A-4(II)). Consumption of purines and amide III (1300–1320 cm–1)41,42 was observed to be maximum at both the locations in the cell at 2 and 24 hpi (Figure 2A-5(I),(II)). Fatty acids and triglycerides (1439–1448 cm–1)43,44 from the nucleus showed their highest assimilation in the nucleus at 4 and 24 hpi (Figure 2A-6(I)). However, at the peripheral site, fatty acid and triglyceride molecules were used up earlier, starting at 2 and 12 hpi (Figure 2A-6(II)). In the nucleus of HMC-3, phenylalanine, tyrosine, and tryptophan molecules (1600–1628 cm–1),45,46 and reserves were consumed maximally at 6 hpi, followed by replenishment with highest anabolic activity at 24 hpi (Figure 2A-7(I)), although at the periphery the consumption of these amino acid molecules started as early as 2 hpi and was replenished at 6 and 36 hpi (Figure 2A-7(II)). The Raman signals originating from OH–NH–CH stretching vibrations (2300–3800 cm–1)47 in the nucleus showed maximum catabolism of associated molecules at 6 and 24 hpi (Figure 2(A)-8(I)). Comparatively, the highest amounts of the aforesaid molecules appeared at 4 and 36 hpi (Figure 2A-8(II)).
Figure 2.
(A) Expression of various biomolecules at different time points post EBV infection in HMC-3 cells. The intensity levels of each biomolecule group upon EBV infection are plotted separately in comparison to those of uninfected cells. The data was recorded at time intervals of 2, 4, 6, 12, 24, and 36 hpi for HMC-3 cells. Changes in the Raman intensity related to nucleic acid, amino acids, lipids, and carbohydrates were observed in the microglial cell line. (B) Expression of various biomolecules at different time points post EBV infection in U-87 MG cells. The intensity levels of each biomolecule group upon EBV infection are plotted separately in comparison to those of uninfected cells. The data was recorded at time intervals of 2, 4, 6, 12, 24, 36, and 48 hpi for U-87 MG cells. The astroglial cells showed changes in the Raman intensity associated with polysaccharides, amino acids, nucleotides, and lipids.
The amounts of proline, hydroxyproline, glycogen, and lactic acid molecules (918–930 cm–1)48,49 in the astroglial nucleus were elevated at 4, 24, and 48 hpi (Figure 2B-1(I)). However, the reserves of these molecules diminished at the periphery at 2 hpi with subsequent restoration at 6 and 36 hpi (Figure 2B-1(II)). As compared to the uninfected samples, the amounts of phenylalanine, glucose, saccharides, and carbohydrates (1096–1117 cm–1)36,42,46 were not altered considerably in the nucleus at 2 hpi. However, in the peripheral region, consumption of phenylalanine and saccharide moieties was maximum at 2 hpi, followed by subsequent replenishment at 6 hpi (Figure 2B-2(II)). The Raman signals generated due to the polynucleotide chain and nucleic acids (1334–1342 cm–1)34,48,45,51 were reduced at 2, 6, and 36 hpi in the nucleus, depicting marked catabolic activity, followed by an intermittent anabolic process at 24 and 48 hpi, which restored the pool (Figure 2B-3(I)). At the periphery, maximum consumption of the polynucleotide chain and nucleic acids was observed at 2 and 24 hpi with a brief replenishment at 6 and 36 hpi (Figure 2B-3(II)). Upon EBV infection, the astroglial nucleus showed maximum consumption of fatty acids and triglycerides (1442–1453 cm–1)52−54 at 2, 6, and 36 hpi (Figure 2B-4(I)), whereas at the periphery, the fatty acid molecules were maximally consumed at 2 and 24 hpi with intermittent restoration of the basal amount at 6 hpi (Figure 2B-4(II)). The molecules related to the amide I (1653–1664 cm–1)42,50,55,56 group showed catabolic activity on EBV infection in general at both the locations in the cell. Their maximum consumption in the nucleus was observed at 6 and 36 hpi (Figure 2B-5(I)) and at 2, 24, and 48 hpi at the cell periphery (Figure 2B-5(II)). The Raman signals originating from CH2 asymmetric stretch due to proteins (2928–2942 cm–1)57 showed their maximum assimilation at both the cellular locations at 2 and 36 hpi (Figure 2B-6(I)). Apart from this, at 6 hpi, the nucleus showed catabolic activity, whereas at the periphery, anabolic activity restored the amount of these molecules (Figure 2B-6(II)).
Varying Biomolecular Expression at the Nucleus and the Periphery of Glial Cells with Continuing EBV Infection
To understand the alterations occurring in biomolecular expression in the continuous cycle of infection progression, we compared the signal intensities at subsequent time points. The gradual increase in intensity was analyzed at successive time frames throughout the infection in terms of predefined intervals, i.e., 0–2, 2–4, 4–6, 6–12, 12–24, and 24–36 hpi for HMC-3 cells and an additional interval of 36–48 hpi for U-87 MG cells.
For HMC-3 cells, in the interval of 0–2 hpi, we observed an increase in the signal intensities of glucose and lipids (Figure 3A) in the nucleus, whereas at the cell periphery, an increase in the intensity of PIP, DNA, and its phosphodiester backbone was obtained (Figure 3B). In the time span of 4–6 hpi, the amount of polysaccharide was increased at the cell periphery (Figure 3B). Later during 6–12 hpi, the nuclei of microglial cells showed maximum activity with increased levels of DNA and its phosphodiester backbone, glycogen, nucleotides (guanine and cytosine), and amino acids such as proline and tyrosine (Figure 3A). However, the peripheral region maintained its status quo without any changes (Figure 3B). However, during the last leg of our experimental infection from 24 to 36 hpi, the activity of amide III, nucleotides of DNA (guanine, cytosine, adenine, and thymine), and fatty acids was highest in the nucleus (Figure 3A). On the contrary, the amount of cholesterol and polysaccharides was highest in the peripheral region (Figure 3B).
Figure 3.
Representative view of changes in biomolecular activity upon continuous infection progression. Briefly, the biomolecules represented by their corresponding wavenumber values are plotted against the time intervals of their occurrence. The recorded data was plotted for consequent time intervals of 0–2, 2–4, 4–6, 6–12, 12–24, and 24–36 for HMC-3 and an additional 36–48 hpi for U-87 MG cells at both cellular locations (nucleus and periphery) separately. The maximum molecular activity was recorded (A) at the nucleus of HMC-3 cells during 0–2, 6–12, and 24–36 hpi, (B) at the periphery of HMC-3 cells during 0–2, 4–6, and 24–36 hpi, (C) at the nucleus of U-87 MG cells during 4–6, 6–12, 12–24, and 36–48 hpi, and (D) at the periphery of U-87 MG cells during 0–2 and 4–6 hpi.
During the early phase of infection, i.e., from 0 to 2 hpi, purines of DNA and tryptophan showed a considerable increase in the nucleus of U-87 MG (Figure 3C). The cell periphery marked an increase in the levels of PIP, cholesterol, lipids, and protein stretch during the same time frame (Figure 3D). As the infection progressed from 2 to 4 hpi, the Raman intensities corresponding to lactic acid, proline, and RNA were considerably altered in the nucleus (Figure 3C). On the contrary, at the periphery, the amounts of proline molecule and amide III group were enhanced (Figure 3D). During the time interval of 4–6 hpi, a variation was accounted for the Raman intensity associated with PIP, cholesterol, polysaccharides, DNA, and glycogen molecules (Figure 3C). In the same time span at the periphery, a change was observed in the intensity corresponding to phenylalanine, vibrations due to OH–NH–CH bond stretching, and lipids (Figure 3D). Later in the time interval of 6–12 hpi, we documented a change in the levels of lipid- and protein-associated moieties, DNA, and glycogen molecules in the nucleus (Figure 3C). At the periphery in the same time interval, the biomolecular activity remained unchanged (Figure 3D). Lastly, from 36 to 48 hpi, the nuclear Raman intensity demonstrated an increase in the levels of PIP and cholesterol (Figure 3C). Changes due to protein stretch and OH–NH–CH stretching were observed at 36–48 hpi at the cell periphery (Figure 3D).
Pathway Analysis of Selected Biomolecules
Further, the information regarding the biomolecules was uploaded to Qiagen’s IPA system. The global molecular network available in the Ingenuity pathway knowledge base (IPKB) identified canonical pathways and gene networks associated with particular biomolecule-related neuropathologies. We obtained a connectome with the set filters of virus infection and associated diseases including neurodegeneration, suggesting high involvement of cholesterol in various pathways. Prominent molecules obtained on infection of microglia (HMC-3) were cholesterol, cholesterol esters, PIP, 3-nitrotyrosine, lactic acid, lipids, and glucose (Figure 4A). Notably, cholesterol trafficking is prominently affected in AD and MS pathologies via ABCA-1 (ATP binding cassette subfamily A member 1) transporter and modulation of apolipoprotein (APOA and APOE) metabolism.58 Yet another group of molecules involved in cholesterol metabolism and implied in MS,59 AD, and PD pathologies is that involved in membrane trafficking. These molecules, sterol-O-acyltransferase-1 (SOAT-1), sphingosine-1-phosphate lyase-1 (SGPL-1), and synuclein α (SNCA), are involved in cholesterol transport in and out of the cell and in presynaptic signaling. The connectome indicated various other membrane proteins such as matrix-associated protein-2 (MAP-2), CD44 (a cell surface marker), proteolipid protein-1 (PLP-1), and amyloid precursor protein (APP) directly or indirectly related to cholesterol metabolism in development of neurodegenerative pathologies. These molecules mainly act as cell surface receptors and are responsible for maintaining cell integrity, cell–cell interactions, adhesion, and migration. APP, PLP-1, and MAP-2 are widely recognized in AD, whereas MBP (myelin basic protein) linked with lipid metabolism is a primary marker for neurodegeneration observed in MS and ALS. Cell damage caused by oxidative stress generated due to reactive oxygen species (ROS) is one of the prevailing hypotheses of neurodegenerative pathology. Being rich in peroxidation susceptible substrates and having high oxygen consumption, the brain is more prone to damage caused by ROS. Molecules involved in the oxidative stress hypothesis of neurodegeneration were also interlinked with the ones we found in our study. For example, PSEN-1 (presenilin-1), which is thoroughly studied in MS,60 AD, and PD pathologies, is the connecting link among PIP, 3-nitrotyrosine, lactic acid, cholesterol ester, and cholesterol. Additionally, molecules involved in the oxidative stress hypothesis such as BACE-1 (β site APP cleaving enzyme-1) and AβPP also interlink with the cholesterol metabolism.
Figure 4.
(A) Connectome representing the interlinks of biomolecules observed to be modulated on EBV infection in HMC-3 (microglia). The network depicts the molecules implied in various neurodegenerative pathologies (according to the IPA knowledge database). Molecular metabolisms related to (A) cholesterol, lipids, lactic acid metabolism, and PIP signaling cascade were recorded to be modulated in HMC-3 cells. (B) Connectome representing the interlinks of biomolecules observed to be modulated on EBV infection in U-87 MG (astroglia). The network depicts the molecules implied in various neurodegenerative pathologies (according to the IPA knowledge database). Molecular metabolisms related to (B) sterol biosynthesis, lipid transport, and microtubule cytoskeleton were recorded to be altered in U-87 MG cells.
In the case of astrocytes, we found alterations in pathways implied in sterol biosynthesis, lipid transport, microtubule cytoskeleton constitution, and various endoplasmic reticulum (ER) proteins, along with the molecules involved in transcription regulation, metal ion binding, and various kinases (Figure 4B). Cholesterol was found to be related to most of the molecules compared to any other biomolecule under investigation. It is known that cholesterol metabolism is affected via modulation of the enzymes involved in sterol biosynthesis, such as sterol-C5-desaturase (SC5D), 24-dehydrocholesterol reductase (DHCR24), squalene monooxygenase (SQLE), and lecithin-cholesterol acyltransferase (LCAT). Dysregulation of sterol biosynthesis is strongly implied in neurodegenerative pathology like AD.61 Other molecules concerned with AD and MS pathologies are also affected in astroglia on EBV infection such as those involved in lipid transport pathway (involving ABCA-1, APOE, and APOA1)62−64 and microtubule cytoskeleton proteins (PLP-1, MAP-2, and APP),65,66 in addition to PMP-22 (peripheral myelin protein-22)67 and other membrane proteins (matrix metalo-endopeptidases or MME, BACE-1, and sonic hedgehog or SHH).68−70 Some other molecules including glutamate ionotropic receptor NMDA type subunit 1 (GRIN1)71 and sodium voltage-gated channel α subunit 11 (SCN11A)72 were also reported in this regard. In addition, certain kinases such as protein kinase C ζ (PRKCZ),73 erb-b2 receptor tyrosine kinase 2 (ERBB2),74 and neurotrophic receptor tyrosine kinase 2 (NTRK2),75 also associated to cholesterol metabolism, were observed in astrocytes upon EBV infection. Interestingly, these molecules are reported to be associated with AD, PD, and other neurodegenerative pathologies. Cholesterol metabolism pathways associated with transcription regulator factors such as cAMP-responsive element-binding protein 1 (CREB1), cAMP response element mediator (CREM), MAF (transcription factor), and methyl CpG binding protein (MECP) contemplated in our study were also implied in Huntington’s disease (HD)76 and AD,76,77 respectively. Apart from cholesterol, hyaluronic acid (HA) is another molecule modulated on EBV infection. Nonetheless, glycosaminoglycan-binding proteins such as BCAN (brevican core protein),78 CD44 (CD44 antigen),79 and HAPLN4 (hyaluronan and proteoglycan link protein 4)80 related to the HA metabolism are involved in PD pathology. Various other molecules related to HA metabolism such as insulin-like growth factor (IGF1), kinases protein tyrosine kinase 2 (PTK2), matrix metalo-proteinases (MMP14, MMP9), and hyaluronan synthase 3 (HAS3) could be responsible for altered HA metabolism on EBV infection ultimately leading to neurodegeneration.
Discussion
The presence of EBV has been prevalently reported in CSF samples and postmortem brain tissue of patients suffering from neurodegenerative disorders, such as MS,81 AD,82 PD,83 ALS,81,84 etc., although how the virus gains entry and propagates inside the cells of the host brain is yet to be elucidated at the biomolecular level. Traditional biomolecular techniques used to detect the virus infection in any cell utilize the expression of viral transcript or proteins in the host.85 Detection of infection, thereby, becomes organ- and individual-specific, costly, time-consuming, and handling-dependent, along with a low reproducibility rate. RS on the other hand can trace the infection process with minute biomolecular changes occurring in the host cell on virus infection noninvasively and more robustly in lesser time and is also independent of handling constraints.86 This advantage gives an upper edge to the technique for the early detection of the virus during the infection process. As discussed previously, a virus infection cycle in a mammalian cell follows the steps of attachment, penetration, uncoating, genomic replication, assembly, and finally viral egress. All of these processes are biochemically driven and can be related to changes in the signature Raman spectrum.87 We observed sequential biomolecular changes occurring in the astrocytes and microglial cell lines post-EBV infection using RS. The information thus obtained provided an insight into the probable virus control and the host cell modulations. Our data suggested differences in the infection pattern of the virus in the glial cell repertoire.
Raman signals obtained during initial phases of infection, i.e., in the time duration between causing EBV infection to a healthy cell and 2 hpi, showed increased levels of glucose and lipid molecules in the nucleus and enhanced DNA and PIP activity at the periphery of the microglial cells, whereas Raman bands relating to PIP, lipids (cholesterol and cholesterol esters), and proteins were observed at the periphery of astroglial cells. It is suggested that lipids might be involved in the process of cell membrane modulation to facilitate EBV entry in the cells. In addition, until the elapse of 2 hpi, EBV (a DNA virus) was present at the cell periphery of the glial cells, and alterations in the signaling processes involving PIP were ongoing, implying that signaling molecules such as PIP might help in attachment and entry of EBV inside the glial cells. Many viruses have developed mechanisms to take advantage of phosphatidylinositol (PI)-mediated signaling cascade to gain entry and trigger modulations in the cell microenvironment beforehand to favor the virus’s survival.88 Although PI is the least abundant phospholipid in the cell membrane, it plays a crucial role in modulating the traffic in and out of the cell. It does so by getting differentially phosphorylated and giving rise to various PIP species.89 Class-I PI-3 kinase (PI-3K) is the most extensively exploited signaling pathway by various viruses during the entry process. For example, HIV-1 is known to employ the PI-3K-mediated micropinocytosis mechanism to modulate the cell cytoskeleton for gaining entry into the cell.90 Various other studies have also reported the alteration of pathways involving PIP in the successful establishment of virus infections of KSHV, human herpesvirus-8 (HHV-8),91 HSV-1,88 HCV,92 Zaire Ebola virus,93 and VZV.94 Thus, our experiments suggested its role in EBV’s entry inside the glial cells. Interestingly, PIP is implied in the processing of APP as well and thereby in the development of AD pathologies such as plaque formation or neurofibrillary tangle (NFT) deposition.95 It also suggested a probable PIP-mediated role of EBV in neurodegeneration. Our experiments also indicated that EBV infection manipulates sterol metabolism in astroglial cells on entry. Interestingly, the brain is the most cholesterol-rich organ, consisting of about 20–25% of the total cholesterol content of the whole body. Sterol metabolism naturally being one of the cornerstones of the energy cycle in the brain plays an important role in numerous neural metabolic pathways. Disruption of sterol homeostasis in the brain may be linked with multiple neurodegenerative pathologies such as MS, AD, PD, HD, and ALS.96−98 Any disturbance in the enzymatic mechanism of cholesterol synthesis, trafficking, or dissolution would lead to abnormal deposition of various sterol moieties in the intracellular or extracellular matrix. This might cause hindrance in impulse transmission through neurons, leading to atypical pathology of neurodegenerative diseases as AD,99 PD, or Lewy body dementia.100 The capacity of EBV to modulate sterol homeostasis in astroglia is observed in our study, and therefore it is suggested that EBV could also mediate neurodegeneration by dysregulation of the cholesterol metabolism.
By the end of 2 hpi, the Raman signals obtained from the periphery of microglial cells coincide with those obtained at the nucleus. In addition to the continued glucose and lipid metabolism signals from the nucleus, we observed an increase in the expression of PIP and DNA at both locations. The nuclear signals decline slightly thereafter till 4 hpi. These observations point toward an early start of an increase in the DNA activity inside the nucleus of microglial cells by 2 hpi, accompanied by an enhancement in signaling processes throughout the cell, as indicated by the increased signals for PIP or lipid molecules such as cholesterol. Moreover, by the end of 4 hpi, signals from the periphery showed the presence of polysaccharide, protein-related moieties, and purines of nucleic acids. Most biomolecular signals from the nucleus showed a decline in the period of 4–6 hpi, except for a slight increase in the expression of fatty acids at 6 hpi. However, we noticed a probable increase in cellular traffic at the periphery during 4–6 hpi based on the increased activity of cholesterol, PIP, and amino acids (Phe, Tyr, and Trp) at the periphery of microglia. Contrastingly, we recorded a high activity of astroglial nucleus during 4–6 hpi. We surmise that by the end of 4 hpi the virus must have gained entry into the astroglial cell nucleus. Later, upon reaching the nucleus, it probably utilized cholesterol, polysaccharides, and lipid metabolism to carry out its replication. Besides, few reports suggest the exploitation of cholesterol and saccharide moieties to attach and gain entry into the host cell by the herpesvirus family.101
We speculated that after entering the nucleus of a microglial cell, during 6–12 hpi, the virus most likely manipulates nuclear metabolism of glycogen102 and amino acids103 to facilitate its replication cycle. It is noteworthy to state that abnormal glucose metabolism is often associated with MS disease pathology and various neuro-inflammatory disorders.104,105 The microglial nucleus showed maximum activity post 6 hpi till 12 hpi. Enhanced signals for amino acids (Pro and Tyr), glycogen, and DNA metabolism (in the form of signals for DNA, phosphodiester bond, and purines-guanine and cytosine) are observed past 6 h in the nucleus of microglial cells and are maintained till the end of 12 hpi. This coincided with the presence of polysaccharides and amino acids in the nucleus. Nonetheless, in microglia, the activity of most biomolecules at the periphery was downregulated from 6 to 12 hpi, except a slight increase in polysaccharides and amino acids (Pro and Val) signals, whereas in the astroglial cells at 6–12 hpi, further processing of the virus inside the nucleus is speculated, as implied by the expression of various molecules such as triglycerides, fatty acids, lipids, and proteins. Various viruses like dengue (DENV),106 human cytomegalovirus (HCMV),107 herpes simplex virus-1 (HSV-1),108 and EBV109 are known to manipulate the glycolytic pathway for their benefit. These viruses could either utilize glycogen for glycogenolysis to sustain increased energy requirements during replication or fuel fatty acid synthesis (HCMV) or enhance pyrimidine production (HSV-1) as required.110 The manipulation of glycogen metabolism by various viruses to facilitate their replication cycle enabled us to conclude that EBV may modulate glycogen metabolism for aiding its replication cycle in the microglia occurring at 6–12 hpi. Importantly, Pro and Tyr are involved in cell signaling pathways such as those regulating proliferation111 and ROS scavenging.112 Modulation of amino acid metabolism similar to that of Tyr and Phe is known to be associated with HIV-1113 and HBV infections.114
Then, in the duration of 12–24 hpi, we hypothesized that successive steps of the virus packaging and transport occurred in the astrocytes indicated by the presence of nucleotide molecules at the periphery. However, the virus replication cycle repeated after completion of 24 hpi, as suggested by the repetition of signals obtained for PIP and cholesterol from the nucleus, whereas signals collected from the periphery indicate the presence of nucleotides and proteins, which might denote the viral egress from the cell at later time points (36–48 hpi). Thereafter, in the microglial cell line, plausibly, the process of viral packaging is initiated (periphery) at 24 hpi and is carried out until 36 hpi. Enhancements in signals produced from amide bond and amino acids (Phe, Tyr, and Trp), nucleotides, and fatty acids corroborate our speculations, as the molecules falling in the broad category of protein and lipids are believed to be utilized by certain viruses such as HCMV to facilitate their survival inside the host. In fact, a wide variety of viruses, such as HCMV, HSV, EBV, DENV, hepatitis B virus (HBV), hepatitis-C virus (HCV), vaccinia virus, and KSHV to name a few, reportedly alter fatty acid metabolism.114,115 Lipids and fatty acids being the second preferable energy source after glucose for the brain play a major role in neurophysiology. Thus, any disturbance in the homeostasis of the lipid metabolism in the brain could result in grave consequences. For instance, impaired enzymatic cascades (such as sphingolipid pathway) or oxidative stress resulting in dysregulation of lipid metabolism and lipid rafts are well described to be associated with amyloid plaque and NFT deposition causing AD,116 PD, or HD.97 Notably, various lipid molecules are enhanced in the brain of MS patients, thus giving rise to a specific lipidomic profile.117 Also, a perturbed cholesterol pathway is associated with MS.96 After 36 hpi, we suspect that many cellular processes simultaneously occur as the Raman signals thus obtained are mixed (pertaining to the obtained signals corresponding to molecules such as phosphodiester, Pro, Tyr, and lipids). These processes may occur to facilitate the initiation of the next virus replication cycle and/or carry on the ongoing cycle.
Conclusions
Time-dependent in vitro spatial Raman spectroscopy carried out on different regions of glial cells shows the temporal evolution of EBV infection, enabling one to understand the virus influencing mechanism. In brief, the investigation directed us to believe that EBV enters the glial cells probably in the first 2 hpi by utilizing PIP-dependent signaling pathways, whereas further processing of the virus differs slightly among microglial and astroglial cells. To reach inside and manipulate the nuclear microenvironment of microglial cells, it takes up to 6 hpi and up to 4 hpi in the astroglial cells. Moreover, during its nuclear hijack process from 6 to 12 hpi, the virus manipulates glycogen and amino acid metabolism in the microglial cells. While in the case of the astroglial cells, fatty acids and triglyceride metabolism is affected at 6–12 hpi. Later, during 12–24 hpi, the processes of replication and cellular transport are still carried on in the microglia, whereas EBV showed signs of viral packaging and transport being initiated in astroglial cells. It is only after 24 hpi that viral packaging and egress is initiated in microglial cells. However, in astroglia, from 24 hpi onward we noticed overlapping signals for replication and viral egress. Thus, the study aided us to further our understanding of the involvement of different biomolecules at various stages of EBV infection progression in two different glial cells. With further advances in technology in the future, the application of RS could extend to differentiating the viral infection stages in clinical settings and help in noninvasive and early disease diagnosis. The recent outbreak of SARS-CoV2 has brought forth the importance of such rapid diagnostic tools in the detection of virus infection.119 The temporal and spatial Raman spectroscopic technique appears to be a step forward toward understanding the viral biology after infection in host cells and also assisting in a comparative analysis of replication kinetics in different cells on infection with multitropic viruses such as EBV.
Materials and Methods
Cell Culture
HMC-3 (SV-40 transformed, immortalized microglial cell lines were obtained from Dr. Anirban Basu’s laboratory, National Brain Research Centre, Delhi) and U-87 MG cell lines (glioblastoma cells of epithelial origin from the human brain were purchased from the National Centre for Cell Sciences, Pune) were cultured in high-glucose-containing Dulbecco’s modified Eagle’s medium (HiMedia) supplemented with 10% fetal bovine serum (Invitrogen), 50 units/mL penicillin, and 100 μg/mL streptomycin (Invitrogen) over coverslips. The cells were incubated at 37 °C with 5% CO2.
Virus Isolation and Purification
HEK-293T cells (a kind gift from Prof. Erle S. Robertson’s laboratory, University of Pennsylvania) transformed with GFP-tagged virus-containing bacmid were used to obtain EBV particles.118 Briefly, to obtain the virus particles, lytic induction was given to cells with 20 ng/mL tetradecanoyl phorbol acetate and 3 mM butyric acid at 60% cell confluence for 4–5 days. The cell suspension was centrifuged at 775g for 20 min, and the supernatant was then filtered through a 0.45 μm membrane (Millipore). The filtrate was ultracentrifuged at 65 291g for 90 min at 4 °C. The concentrated virus pellet was resuspended in a suitable amount of culture media and stored at −80 °C until further use.
EBV Infection in Glial Cells
An appropriate concentration of EBV for each cell line was investigated. The U-87 MG cells (astrocytes) cultured onto the coverslips were infected with EBV at an MOI (multiplicity of infection) of 2.5 and incubated for the duration of 2, 4, 6, 12, 24, 36, and 48 h. Also, 5.0 MOI of EBV was used for infecting HMC-3 cells (microglia). The microglial cells were incubated with the virus for the duration of 2, 4, 6, 12, 24, and 36 h. After collecting the coverslips at the respective time points, the cells grown on these coverslips were fixed using 4% paraformaldehyde (PFA) for 20 min at room temperature. The coverslips were mounted onto glass slides before visualization on the Raman spectrometer.
Raman Spectroscopy
Raman spectroscopy was performed on a LabRAM HR Evolution (Horiba-Jobin Yvon) spectrometer using a He-Ne laser (λexc = 633 nm, ∼10 mW) excitation source. The sample was focused with the help of a microscope objective to probe the nucleus and the periphery of the cell. The Raman measurement was performed using minimum possible laser power controlled using an ND filter to avoid any laser-related damage to the cells. The Raman study was performed on uninfected (UI) and 2, 4, 6, 12, 24, 36, and 48 hpi of respective cells. The laser was focused onto the nuclei and cell body (periphery) separately as visualized on the microscope to acquire signals from respective places.
Data Analysis
Graphical Analysis
All of the raw data of Raman vibrational intensity obtained from the Raman spectroscope within wavenumber ranges of 400–3500 cm–1 (HMC-3) and 400–4000 cm–1 (U-87 MG) was smoothened by 20 points for better visibility. Signals from common cell culture artifacts such as culture medium, phosphate-buffered saline (PBS), PFA, coverslips, and glass slides were subtracted from all of the samples. Thereafter, we selected the most relevant wavenumber peaks from the graph based on intensity.
Statistical Analysis
The dimensionality of the raw data was reduced using principal component analysis (PCA) on SPSS software. The total numbers of selected peaks were verified using PCA. Mann–Whitney U test (α = 0.05) was applied to the screened data consisting of wavenumber ranges corresponding to the peaks for comparison of Raman intensities at subsequent time points. Additionally, we also included the odds ratio (OR) analysis to enhance data confidence.
Interactome Study
The selected wavenumber peaks were cross-referenced with the available literature to verify the corresponding biomolecules. The biomolecules were then uploaded on Qiagen’s Ingenuity Pathway Analysis (IPA) software to obtain an interconnection between them. Thereafter, a global molecular network available on the Ingenuity pathway knowledge base (IPKB) was used as a reference to perform analysis of canonical pathways, diseases, functions, and gene networks. The analysis gave us hits that are most significantly related to the biomolecular changes occurring in viral infection and neurodegenerative diseases.
Acknowledgments
Facilities received from the Department of Science and Technology (DST), Government of India, under FIST Scheme (grant number SR/FST/PSI-225/2016) are acknowledged. We are thankful to Prof. Earl S. Robertson (U. Penn.) and Dr. Anirban Basu (NBRC, Delhi) for their kind gift of the cell lines. One of the authors (R.K.) acknowledges financial support from the Science and Engineering Research Board, Government of India (Grant CRG/2019/000371). One of the authors (D.K.P.) acknowledges the Council of Scientific and Industrial Research (CSIR) for financial assistance (File 09/1022(0039)/2017-EMR-I). We appreciate our laboratory colleagues (from Infection-bioengineering group), in particular Omkar Indari, for insightful discussions and advice and Buddhadev Baral for his help in performing the experiments. We gratefully acknowledge the Indian Institute of Technology Indore for providing facilities and support.
Author Contributions
∥ D.T. and S.J. contributed equally to this work.
We thank the Council of Scientific and Industrial Research grant no. 37(1693)/17/EMR-II, Department of Science and Technology, and Ramanujan fellowship grant no. SB/S2/RJN-132/20/5, the Ministry of Human Resource, for fellowship to S.J. and D.T. in the form of research stipend. The funding organization has not played any role in the study design or the preparation of the manuscript.
The authors declare no competing financial interest.
References
- Kuhar N.; Sil S.; Verma T.; Umapathy S. Challenges in application of Raman spectroscopy to biology and materials. RSC Adv. 2018, 8, 25888–25908. 10.1039/C8RA04491K. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barr A. J. The biochemical basis of disease. Essays Biochem. 2018, 62, 619–642. 10.1042/EBC20170054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor H. L.; Wu C. L.; Chen Y. C.; Wang P. G.; Gonzalez J. T.; Betts J. A. Post-Exercise Carbohydrate-Energy Replacement Attenuates Insulin Sensitivity and Glucose Tolerance the Following Morning in Healthy Adults. Nutrients 2018, 10, 123. 10.3390/nu10020123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boyer S. W.; Barclay L. J.; Burrage L. C. Inherited Metabolic Disorders: Aspects of Chronic Nutrition Management. Nutr. Clin. Pract. 2015, 30, 502–510. 10.1177/0884533615586201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parhofer K. G. The Treatment of Disorders of Lipid Metabolism. Dtsch. Arztebl. Int. 2016, 113, 261–268. 10.3238/arztebl.2016.0261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borges R. D.; Navarro R. S.; Giana H. E.; Tavares F. G.; Fernandes A. B.; Silveira Junior L. Detecting alterations of glucose and lipid components in human serum by near-infrared Raman spectroscopy. Res. Biomed. Eng. 2015, 31, 160–168. 10.1590/2446-4740.0593. [DOI] [Google Scholar]
- Javanmard M.; Davis R. W.. Surface-Enhanced Raman Scattering (SERS) for Detection of Phenylketonuria for Newborn Screening. In Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XI; International Society for Optics and Photonics, 2014; Vol. 8954. [Google Scholar]
- Kang J. W.; Park Y. S.; Chang H.; Lee W.; Singh S. P.; Choi W.; et al. Direct observation of glucose fingerprint using in vivo Raman spectroscopy. Sci. Adv. 2020, 6, 5206. 10.1126/sciadv.aay5206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jess P. R. T.; Smith D. D. W.; Mazilu M.; Dholakia K.; Riches A. C.; Herrington C. S. Early detection of cervical neoplasia by Raman spectroscopy. Int. J. Cancer 2007, 121, 2723–2728. 10.1002/ijc.23046. [DOI] [PubMed] [Google Scholar]
- Pence I. J.; Beaulieu D. B.; Horst S. N.; Bi X.; Herline A. J.; Schwartz D. A.; Mahadevan-Jansen A. Clinical characterization of in vivo inflammatory bowel disease with Raman spectroscopy. Biomed. Opt. Express 2017, 8, 524–535. 10.1364/BOE.8.000524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Czamara K.; Majzner K.; Selmi A.; Baranska M.; Ozaki Y.; Kaczor A. Unsaturated lipid bodies as a hallmark of inflammation studied by Raman 2D and 3D microscopy. Sci. Rep. 2017, 7, 40889 10.1038/srep40889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singh S. P.; Xia A.; Tusty M.; Malkovskiy A. V.; Easwaran M.; Zarabanda D.; et al. Identification of early inflammatory changes in the tympanic membrane with Raman spectroscopy. Analyst 2019, 144, 6721–6728. 10.1039/C9AN01772K. [DOI] [PubMed] [Google Scholar]
- Patel S. K.; Rajora N.; Kumar S.; Sahu A.; Kochar S. K.; Krishna C. M.; et al. Rapid Discrimination of Malaria- and Dengue-Infected Patients Sera Using Raman Spectroscopy. Anal. Chem. 2019, 91, 7054–7062. 10.1021/acs.analchem.8b05907. [DOI] [PubMed] [Google Scholar]
- Hamden K. E.; Bryan B. A.; Ford P. W.; Xie C.; Li Y.-Q.; Akula S. M. Spectroscopic analysis of Kaposi’s sarcoma-associated herpesvirus infected cells by Raman tweezers. J. Virol. Methods 2005, 129, 145–151. 10.1016/j.jviromet.2005.05.018. [DOI] [PubMed] [Google Scholar]
- Driskell J. D.; Zhu Y.; Kirkwood C. D.; Zhao Y.; Dluhy R. A.; Tripp R. A. Rapid and sensitive detection of rotavirus molecular signatures using surface enhanced Raman spectroscopy. PLoS One 2010, 5, e10222 10.1371/journal.pone.0010222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sehrawat S.; Kumar D.; Rouse B. T. Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?. Front. Cell. Infect. Microbiol. 2018, 8, 177. 10.3389/fcimb.2018.00177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zanella L.; Riquelme I.; Buchegger K.; Abanto M.; Ili C.; Brebi P. A reliable Epstein-Barr Virus classification based on phylogenomic and population analyses. Sci. Rep. 2019, 9, 9829 10.1038/s41598-019-45986-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smatti M. K.; Al-Sadeq D. W.; Ali N. H.; Pintus G.; Abou-Saleh H.; Nasrallah G. K. Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Front. Oncol. 2018, 8, 211. 10.3389/fonc.2018.00211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang Y.; Gao F. Clinical characteristics of primary and reactivated Epstein-Barr virus infection in children. J. Med. Virol. 2020, 26202 10.1002/jmv.26202. [DOI] [PubMed] [Google Scholar]
- Jha H. C.; Pei Y.; Robertson E. S. Epstein-Barr Virus: Diseases Linked to Infection and Transformation. Front. Microbiol. 2016, 7, 1602 10.3389/fmicb.2016.01602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carbone I.; Lazzarotto T.; Ianni M.; Porcellini E.; Forti P.; Masliah; et al. Herpes virus in Alzheimer’s disease: relation to progression of the disease. Neurobiol. Aging 2014, 35, 122–129. 10.1016/j.neurobiolaging.2013.06.024. [DOI] [PubMed] [Google Scholar]
- Bu X.-L.; Wang X.; Xiang Y.; Shen L.-L.; Wang Q.-H.; Liu Y.-H.; et al. The association between infectious burden and Parkinson’s disease: A case-control study. Parkinsonism Relat. Disord. 2015, 21, 877–881. 10.1016/j.parkreldis.2015.05.015. [DOI] [PubMed] [Google Scholar]
- Burnard S.; Lechner-Scott J.; Scott R. J. EBV and MS: Major cause, minor contribution or red-herring?. Mult. Scler. Relat. Disord. 2017, 16, 24–30. 10.1016/j.msard.2017.06.002. [DOI] [PubMed] [Google Scholar]
- Schneider-Schaulies J. Cellular receptors for viruses: links to tropism and pathogenesis. J. Gen. Virol. 2000, 81, 1413–1429. 10.1099/0022-1317-81-6-1413. [DOI] [PubMed] [Google Scholar]
- Puelles V. G.; Lütgehetmann M.; Lindenmeyer M. T.; Sperhake J. P.; Wong M. N.; Allweiss L.; et al. Multiorgan and Renal Tropism of SARS-CoV-2. N. Engl. J. Med. 2020, 383, 590 10.1056/NEJMc2011400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miner J. J.; Diamond M. S. Zika Virus Pathogenesis and Tissue Tropism. Cell Host Microbe 2017, 21, 134–142. 10.1016/j.chom.2017.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shannon-Lowe C.; Rowe M. Epstein Barr virus entry; kissing and conjugation. Curr. Opin. Virol. 2014, 4, 78–84. 10.1016/j.coviro.2013.12.001. [DOI] [PubMed] [Google Scholar]
- Nemerow G. R.; Houghten R. A.; Moore M. D.; Cooper N. R. Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell 1989, 56, 369–377. 10.1016/0092-8674(89)90240-7. [DOI] [PubMed] [Google Scholar]
- Jha H. C.; Mehta D.; Lu J.; El-Naccache D.; Shukla S. K.; Kovacsics C.; et al. Gammaherpesvirus Infection of Human Neuronal Cells. mBio 2015, 6, e01844-15 10.1128/mBio.01844-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borza C. M.; Hutt-Fletcher L. M. Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus. Nat. Med. 2002, 8, 594–599. 10.1038/nm0602-594. [DOI] [PubMed] [Google Scholar]
- Ilyushina N. A.; Ikizler M. R.; Kawaoka Y.; Rudenko L. G.; Treanor J. J.; Subbarao K.; et al. Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium. J. Virol. 2012, 86, 11725–11734. 10.1128/JVI.01477-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chu H.; Chan J. F.-W.; Yuen T. T.-T.; Shuai H.; Yuan S.; Wang Y.; et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe 2020, e14–e23. 10.1016/S2666-5247(20)30004-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mrozek-Gorska P.; Buschle A.; Pich D.; Schwarzmayr T.; Fechtner R.; Scialdone A.; et al. Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection. Proc. Natl. Acad. Sci. U.S.A. 2019, 116, 16046–16055. 10.1073/pnas.1901314116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Halder S.; Murakami M.; Verma S. C.; Kumar P.; Yi F.; Robertson E. S. Early events associated with infection of Epstein-Barr virus infection of primary B-cells. PLoS One 2009, 4, e7214 10.1371/journal.pone.0007214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stone N.; Kendall C.; Shepherd N.; Crow P.; Barr H. Near-infrared Raman spectroscopy for the classification of epithelial pre-cancers and cancers. J. Raman Spectrosc. 2002, 33, 564–573. 10.1002/jrs.882. [DOI] [Google Scholar]
- Kamemoto L. E.; Misra A. K.; Sharma S. K.; Goodman M. T.; Luk H.; Dykes A. C.; et al. Near-Infrared Micro-Raman Spectroscopy for in Vitro Detection of Cervical Cancer. Appl. Spectrosc. 2010, 64, 255–261. 10.1366/000370210790918364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krafft C.; Neudert L.; Simat T.; Salzer R. Near infrared Raman spectra of human brain lipids. Spectrochim. Acta, Part A 2005, 61, 1529–1535. 10.1016/j.saa.2004.11.017. [DOI] [PubMed] [Google Scholar]
- Kendall C.; Day J.; Hutchings J.; Smith B.; Shepherd N.; Barr H.; et al. Evaluation of Raman probe for oesophageal cancer diagnostics. Analyst 2010, 135, 3038–3041. 10.1039/c0an00536c. [DOI] [PubMed] [Google Scholar]
- Ruiz-Chica A. J.; Medina M. A.; Sánchez-Jiménez F.; Ramírez F. J. Characterization by Raman spectroscopy of conformational changes on guanine–cytosine and adenine–thymine oligonucleotides induced by aminooxy analogues of spermidine. J. Raman Spectrosc. 2004, 35, 93–100. 10.1002/jrs.1107. [DOI] [Google Scholar]
- Shetty G.; Kendall C.; Shepherd N.; Stone N.; Barr H. Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus. Br. J. Cancer 2006, 94, 1460 10.1038/sj.bjc.6603102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gniadecka M.; Wulf H. C.; Nymark Mortensen N.; Faurskov Nielsen O.; Christensen D. H. Diagnosis of Basal Cell Carcinoma by Raman Spectroscopy. J. Raman Spectrosc. 1997, 28, 125–129. . [DOI] [Google Scholar]
- Lau D. P.; Huang Z.; Lui H.; Anderson D. W.; Berean K.; Morrison M. D.; et al. Raman spectroscopy for optical diagnosis in the larynx: preliminary findings. Lasers Surg. Med. 2005, 37, 192–200. 10.1002/lsm.20226. [DOI] [PubMed] [Google Scholar]
- Dukor R. K.Vibrational Spectroscopy in the Detection of Cancer. In Handbook of Vibrational Spectroscopy; Wiley, 2006. [Google Scholar]
- Rehman I.; Smith R.; Hench L. L.; Bonfield W. Structural evaluation of human and sheep bone and comparison with synthetic hydroxyapatite by FT-Raman spectroscopy. J. Biomed. Mater. Res. 1995, 29, 1287–1294. 10.1002/jbm.820291016. [DOI] [PubMed] [Google Scholar]
- Silveira L.; Sathaiah S.; Zângaro R. A.; Pacheco M. T. T.; Chavantes M. C.; Pasqualucci C. A. G. Correlation between near-infrared Raman spectroscopy and the histopathological analysis of atherosclerosis in human coronary arteries. Lasers Surg. Med. 2002, 30, 290–297. 10.1002/lsm.10053. [DOI] [PubMed] [Google Scholar]
- Huang Z.; McWilliams A.; Lui H.; McLean D. I.; Lam S.; Zeng H. Near-infrared Raman spectroscopy for optical diagnosis of lung cancer. Int. J. Cancer 2003, 107, 1047–1052. 10.1002/ijc.11500. [DOI] [PubMed] [Google Scholar]
- Lakshmi R. J.; Jyothi Lakshmi R.; Kartha V. B.; Murali Krishna C.; Solomon J. G. R.; Ullas G.; et al. Tissue Raman Spectroscopy for the Study of Radiation Damage: Brain Irradiation of Mice. Radiat. Res. 2002, 157, 175–182. 10.1667/0033-7587(2002)157[0175:TRSFTS]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
- Fullwood L. M.; Griffiths D.; Ashton K.; Dawson T.; Lea R. W.; Davis C.; et al. Effect of substrate choice and tissue type on tissue preparation for spectral histopathology by Raman microspectroscopy. Analyst 2014, 139, 446–454. 10.1039/C3AN01832F. [DOI] [PubMed] [Google Scholar]
- Stone N.; Kendall C.; Smith J.; Crow P.; Barr H. Raman spectroscopy for identification of epithelial cancers. Faraday Discuss. 2004, 126, 141–157. 10.1039/b304992b. [DOI] [PubMed] [Google Scholar]
- Binoy J.; Abraham J. P.; Hubert Joe I.; Jayakumar V. S.; Pettit G. R.; Nielsen O. F. NIR-FT Raman and FT-IR spectral studies and ab initio calculations of the anti-cancer drug combretastatin-A4. J. Raman Spectrosc. 2004, 35, 939–946. 10.1002/jrs.1236. [DOI] [Google Scholar]
- Cheng W.-T.; Liu M.-T.; Liu H.-N.; Lin S.-Y. Micro-Raman spectroscopy used to identify and grade human skin pilomatrixoma. Microsc. Res. Tech. 2005, 68, 75–79. 10.1002/jemt.20229. [DOI] [PubMed] [Google Scholar]
- Talari A. C.; Movasaghi Z.; Rehman S.; Rehman I. U. Raman spectroscopy of biological tissues. Appl. Spectrosc. Rev. 2015, 50, 46–111. 10.1080/05704928.2014.923902. [DOI] [Google Scholar]
- Mahadevan-Jansen A.; Richards-Kortum R. In Raman Spectroscopy for Cancer Detection: A Review, Proceedings of the 19th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. “Magnificent Milestones and Emerging Opportunities in Medical Engineering”, 1997; pp 2722–2728.
- Hanlon E. B.; Manoharan R.; Koo T. W.; Shafer K. E.; Motz J. T.; Fitzmaurice M.; et al. Prospects for in vivo Raman spectroscopy. Phys. Med. Biol. 2000, 45, R1–R59. 10.1088/0031-9155/45/2/201. [DOI] [PubMed] [Google Scholar]
- Bonnier F.; Byrne H. J. Understanding the molecular information contained in principal component analysis of vibrational spectra of biological systems. Analyst 2012, 137, 322–332. 10.1039/C1AN15821J. [DOI] [PubMed] [Google Scholar]
- Sigurdsson S.; Philipsen P. A.; Hansen L. K.; Larsen J.; Gniadecka M.; Wulf H. C. Detection of Skin Cancer by Classification of Raman Spectra. IEEE Trans. Biomed. Eng. 2004, 51, 1784–1793. 10.1109/TBME.2004.831538. [DOI] [PubMed] [Google Scholar]
- Chan J. W.; Taylor D. S.; Zwerdling T.; Lane S. M.; Ihara K.; Huser T. Micro-Raman spectroscopy detects individual neoplastic and normal hematopoietic cells. Biophys. J. 2006, 90, 648–656. 10.1529/biophysj.105.066761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koljenović S.; Schut T. B.; Vincent A.; Kros J. M.; Puppels G. J. Detection of meningioma in dura mater by Raman spectroscopy. Anal. Chem. 2005, 77, 7958–7965. 10.1021/ac0512599. [DOI] [PubMed] [Google Scholar]
- Hirsch-Reinshagen V.; Zhou S.; Burgess B. L.; Bernier L.; McIsaac S. A.; Chan J. Y.; Tansley G. H.; Cohn J. S.; Hayden M. R.; Wellington C. L. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J. Biol. Chem. 2004, 279, 41197–4207. 10.1074/jbc.M407962200. [DOI] [PubMed] [Google Scholar]
- Cosconati S.; Novellino E. The first sphingosine 1-phosphate lyase inhibitors against multiple sclerosis: a successful drug discovery tale. J. Med. Chem. 2014, 57, 5072–5073. 10.1021/jm500845y. [DOI] [PubMed] [Google Scholar]
- Cummings M.; Arumanayagam A. C.; Zhao P.; Kannanganat S.; Stuve O.; Karandikar N. J.; Eagar T. N. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. PLoS One 2018, 13, e0200752 10.1371/journal.pone.0200752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martiskainen H.; Paldanius K. M. A.; Natunen T.; Takalo M.; Marttinen M.; Leskelä S.; et al. DHCR24 exerts neuroprotection upon inflammation-induced neuronal death. J. Neuroinflammation 2017, 14, 215. 10.1186/s12974-017-0991-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gardner L. A.; Levin M. C. Importance of apolipoprotein AI in multiple sclerosis. Front. Pharmacol. 2015, 6, 278. 10.3389/fphar.2015.00278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fitz N. F.; Tapias V.; Cronican A. A.; Castranio E. L.; Saleem M.; Carter A. Y.; et al. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice. Brain 2015, 138, 3699–3715. 10.1093/brain/awv293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chew H.; Solomon V. A.; Fonteh A. N. Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies. Front. Physiol. 2020, 11, 598. 10.3389/fphys.2020.00598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bamburg J. R.; Bloom G. S. Cytoskeletal pathologies of Alzheimer disease. Cell Motil. Cytoskeleton 2009, 66, 635–649. 10.1002/cm.20388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cloake N. C.; Yan J.; Aminian A.; Pender M. P.; Greer J. M. PLP1 mutations in patients with multiple sclerosis: Identification of a new mutation and potential pathogenicity of the mutations. J. Clin. Med. 2018, 7, 342. 10.3390/jcm7100342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jana M.; Pahan K. Astrocytes, Oligodendrocytes and Schwann Cells. Neuroimmun. Pharmacol. 2017, 117–140. [Google Scholar]
- Lyons P. D.; Benveniste E. N. Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease. Glia 1998, 22, 103–112. . [DOI] [PubMed] [Google Scholar]
- Vassar R. Beta-Secretase Cleavage of Alzheimer’s Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE. Science 1999, 286, 735–741. 10.1126/science.286.5440.735. [DOI] [PubMed] [Google Scholar]
- Yao P. J.; Manor U.; Petralia R. S.; Brose R. D.; Wu R. T. Y.; Ott C.; et al. Sonic hedgehog pathway activation increases mitochondrial abundance and activity in hippocampal neurons. Mol. Biol. Cell. 2017, 28, 387–395. 10.1091/mbc.e16-07-0553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Intson K.; van Eede M. C.; Islam R.; Milenkovic M.; Yan Y.; Salahpour A.; et al. Progressive neuroanatomical changes caused by Grin1 loss-of-function mutation. Neurobiol. Dis. 2019, 132, 104527 10.1016/j.nbd.2019.104527. [DOI] [PubMed] [Google Scholar]
- Corbett B. F.; Leiser S. C.; Ling H.-P.; Nagy R.; Breysse N.; Zhang X.; et al. Sodium Channel Cleavage Is Associated with Aberrant Neuronal Activity and Cognitive Deficits in a Mouse Model of Alzheimer’s Disease. J. Neurosci. 2013, 33, 7020–7026. 10.1523/JNEUROSCI.2325-12.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crary J. F.; Shao C. Y.; Mirra S. S.; Hernandez A. I.; Sacktor T. C. Atypical protein kinase C in neurodegenerative disease I: PKMζ aggregates with limbic neurofibrillary tangles and AMPA receptors in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006, 65, 319–326. 10.1097/01.jnen.0000218442.07664.04. [DOI] [PubMed] [Google Scholar]
- Wang B.-J.; Her G. M.; Hu M.-K.; Chen Y.-W.; Tung Y.-T.; Wu P.-Y.; et al. ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A. 2017, 114, E3129–E3138. 10.1073/pnas.1618804114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen Z.; Simmons M. S.; Perry R. T.; Wiener H. W.; Harrell L. E.; Go R. C. P. Genetic Association of Neurotrophic Tyrosine Kinase Receptor Type 2 (NTRK2) With Alzheimer’s Disease. Am. J. Med. Genet., Part B 2008, 147, 363–369. 10.1002/ajmg.b.30607. [DOI] [PubMed] [Google Scholar]
- Mantamadiotis T.; Lemberger T.; Bleckmann S. C.; Kern H.; Kretz O.; Martin Villalba A.; et al. Disruption of CREB function in brain leads to neurodegeneration. Nat. Genet. 2002, 31, 47–54. 10.1038/ng882. [DOI] [PubMed] [Google Scholar]
- Kim B.; Choi Y.; Kim H.-S.; Im H.-I. Methyl-CpG Binding Protein 2 in Alzheimer Dementia. Int. Neurourol. J. 2019, 23, S72–S81. 10.5213/inj.1938196.098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hwang H.; Zhang J.; Chung K. A.; Leverenz J. B.; Zabetian C. P.; Peskind E. R.; et al. Glycoproteomics in neurodegenerative diseases. Mass Spectrom. Rev. 2010, 29, 79–125. 10.1002/mas.20221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sherman L. S.; Matsumoto S.; Su W.; Srivastava T.; Back S. A. Hyaluronan Synthesis, Catabolism, and Signaling in Neurodegenerative Diseases. Int. J. Cell Biol. 2015, 368584 10.1155/2015/368584. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Q.; Zhou Q.; Zhang S.; Shao W.; Yin Y.; Li Y.; et al. Elevated Hapln2 Expression Contributes to Protein Aggregation and Neurodegeneration in an Animal Model of Parkinson’s Disease. Front. Aging Neurosci. 2016, 8, 197. 10.3389/fnagi.2016.00197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Abrahamyan S.; Eberspächer B.; Hoshi M.-M.; Aly L.; Luessi F.; Groppa S.; et al. Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis. J. Neurol., Neurosurg. Psychiatry 2020, 91, 681–686. 10.1136/jnnp-2020-322941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kang J.-S.; Liu P.-P. Human herpesvirus 4 and adaptive immunity in Alzheimer’s disease. Signal Transduction Targeted Ther. 2020, 5, 1–2. 10.1038/s41392-020-0125-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Woulfe J.; Gray M. T.; Ganesh M. S.; Middeldorp J. M. Human serum antibodies against EBV latent membrane protein 1 cross-react with α-synuclein. Neurol. Neuroimmunol. Neuroinflammation 2016, 3, e239 10.1212/NXI.0000000000000239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nociti V.; Frisullo G.; Marti A.; Luigetti M.; Iorio R.; Patanella A. K.; et al. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral Sclerosis. J. Neuroimmunol. 2010, 225, 149–152. 10.1016/j.jneuroim.2010.04.007. [DOI] [PubMed] [Google Scholar]
- Peaper D. R.; Landry M. L.. Laboratory Diagnosis of Viral Infection. In Handbook of Clinical Neurology; Tselis A. C.; Booss J., Eds.; Elsevier, 2014; Vol. 123, pp 123–147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Uskoković-Marković S.; Jelikić-Stankov M.; Holclajtner-Antunović I.; Đurđević P. Raman Spectroscopy as a New Biochemical Diagnostic Tool. J. Med. Biochem. 2013, 32, 96–103. 10.2478/jomb-2013-0004. [DOI] [Google Scholar]
- Short K. W.; Carpenter S.; Freyer J. P.; Mourant J. R. Raman spectroscopy detects biochemical changes due to proliferation in mammalian cell cultures. Biophys. J. 2005, 88, 4274–4288. 10.1529/biophysj.103.038604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zheng K.; Xiang Y.; Wang X.; Wang Q.; Zhong M.; Wang S.; et al. Epidermal Growth Factor Receptor-PI3K Signaling Controls Cofilin Activity To Facilitate Herpes Simplex Virus 1 Entry into Neuronal Cells. mBio 2014, 5, e9560 10.1128/mBio.00958-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prestwich G. D. Phosphoinositide signaling; from affinity probes to pharmaceutical targets. Chem. Biol. 2004, 11, 619–637. 10.1016/j.chembiol.2004.03.025. [DOI] [PubMed] [Google Scholar]
- Rocha-Perugini V.; Gordon-Alonso M.; Sánchez-Madrid F. PIP2: choreographer of actin-adaptor proteins in the HIV-1 dance. Trends Microbiol. 2014, 22, 379–388. 10.1016/j.tim.2014.03.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bhatt A. P.; Damania B. AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV. Front. Immunol. 2012, 3, 401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berger K. L.; Cooper J. D.; Heaton N. S.; Yoon R.; Oakland T. E.; Jordan T. X.; et al. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 7577–7582. 10.1073/pnas.0902693106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saeed M. F.; Kolokoltsov A. A.; Freiberg A. N.; Holbrook M. R.; Davey R. A. Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola Virus. PLoS Pathog. 2008, 4, e1000141 10.1371/journal.ppat.1000141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Izmailyan R.; Hsao J.-C.; Chung C.-S.; Chen C.-H.; Hsu PW C.; Liao C.-L.; et al. Integrin 1 Mediates Vaccinia Virus Entry through Activation of PI3K/Akt Signaling. J. Virol. 2012, 86, 6677–6687. 10.1128/JVI.06860-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Morel E.; Chamoun Z.; Lasiecka Z. M.; Chan R. B.; Williamson R. L.; Vetanovetz C.; et al. Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system. Nat. Commun. 2013, 4, 2250 10.1038/ncomms3250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Browne R. W.; Jakimovski D.; Ziliotto N.; Kuhle J.; Bernardi F.; Weinstock-Guttman B.; Zivadinov R.; Ramanathan M. High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus?. J. Clin. Lipidol. 2019, 13, 654–663. 10.1016/j.jacl.2019.06.003. [DOI] [PubMed] [Google Scholar]
- Lim L.; Shui G.; Wenk M. R. Lipid Metabolism in Neurodegenerative Diseases. Lipidomics 2012, 269–296. [Google Scholar]
- Jin U.; Park S. J.; Park S. M. Cholesterol Metabolism in the Brain and Its Association with Parkinson’s Disease. Exp. Neurobiol. 2019, 28, 554–567. 10.5607/en.2019.28.5.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chang T.-Y.; Yamauchi Y.; Hasan M. T.; Chang C. Cellular cholesterol homeostasis and Alzheimer’s disease. J. Lipid Res. 2017, 58, 2239–2254. 10.1194/jlr.R075630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alecu I.; Bennett S. A. L. Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease. Front. Neurosci. 2019, 13, 328. 10.3389/fnins.2019.00328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wudiri G. A.; Pritchard S. M.; Li H.; Liu J.; Aguilar H. C.; Gilk S. D.; et al. Molecular requirement for sterols in herpes simplex virus entry and infectivity. J. Virol. 2014, 88, 13918–13922. 10.1128/JVI.01615-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gualdoni G. A.; Mayer K. A.; Kapsch A.-M.; Kreuzberg K.; Puck A.; Kienzl P.; et al. Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication. Proc. Natl. Acad. Sci. U.S.A. 2018, 115, E7158–E7165. 10.1073/pnas.1800525115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boodhoo N.; Kamble N.; Sharif S.; Behboudi S. Glutaminolysis and Glycolysis Are Essential for Optimal Replication of Marek’s Disease Virus. J. Virol. 2019, 94, 360 10.1128/JVI.01680-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mathur D.; López-Rodas G.; Casanova B.; Marti M. B. Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis. Front. Neurol. 2014, 5, 250. 10.3389/fneur.2014.00250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jope R. S.; Yuskaitis C. J.; Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 2007, 32, 577–595. 10.1007/s11064-006-9128-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fontaine K. A.; Sanchez E. L.; Camarda R.; Lagunoff M. Dengue Virus Induces and Requires Glycolysis for Optimal Replication. J. Virol. 2015, 89, 2358–2366. 10.1128/JVI.02309-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Munger J.; Bajad S. U.; Coller H. A.; Shenk T.; Rabinowitz J. D. Dynamics of the Cellular Metabolome during Human Cytomegalovirus Infection. PLoS Pathog. 2006, 2, e132 10.1371/journal.ppat.0020132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Abrantes J. L.; Alves C. M.; Costa J.; Almeida F. C. L.; Sola-Penna M.; Fontes C. F. L.; et al. Herpes simplex type 1 activates glycolysis through engagement of the enzyme 6-phosphofructo-1-kinase (PFK-1). Biochim. Biophys. Acta, Mol. Basis Dis. 1822, 2012, 1198–1206. [DOI] [PubMed] [Google Scholar]
- Sung W.-W.; Chen P.-R.; Liao M.-H.; Lee J.-W. Enhanced aerobic glycolysis of nasopharyngeal carcinoma cells by Epstein-Barr virus latent membrane protein 1. Exp. Cell Res. 2017, 359, 94–100. 10.1016/j.yexcr.2017.08.005. [DOI] [PubMed] [Google Scholar]
- Vastag L.; Koyuncu E.; Grady S. L.; Shenk T. E.; Rabinowitz J. D. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 2011, 7, e1002124 10.1371/journal.ppat.1002124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choi U. Y.; Lee J. J.; Park A.; Zhu W.; Lee H.-R.; Choi Y. J.; et al. Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 2020, 117, 8083–8093. 10.1073/pnas.1918607117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jiang Y.-C.; Li Y.-F.; Zhou L.; Zhang D.-P. Comparative metabolomics unveils molecular changes and metabolic networks of syringin against hepatitis B mice by untargeted mass spectrometry. RSC Adv. 2020, 10, 461–473. 10.1039/C9RA06332C. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gostner J. M.; Becker K.; Kurz K.; Fuchs D. Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms. Front. Psychiatry 2015, 6, 97. 10.3389/fpsyt.2015.00097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xie Q.; Fan F.; Wei W.; Liu Y.; Xu Z.; Zhai L.; et al. Multi-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells. Sci. Rep. 2017, 7, 41089 10.1038/srep41089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lange P.; Lagunoff M.; Tarakanova V. Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism. Viruses 2019, 11, 119. 10.3390/v11020119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yadav R. S.; Tiwari N. K. Lipid Integration in Neurodegeneration: An Overview of Alzheimer’s Disease. Mol. Neurobiol. 2014, 50, 168–176. 10.1007/s12035-014-8661-5. [DOI] [PubMed] [Google Scholar]
- Nogueras L.; Gonzalo H.; Jové M.; Sol J.; Gil-Sanchez A.; Hervás J. V.; Valcheva P.; Gonzalez-Mingot C.; Solana M. J.; Peralta S.; Pamplona R. Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis. Sci. Rep. 2019, 9, 11313 10.1038/s41598-019-47906-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seo G.; Lee G.; Kim M. J.; Baek S.-H.; Choi M.; Ku K. B.; et al. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor. ACS Nano 2020, 14, 5135–5142. 10.1021/acsnano.0c02823. [DOI] [PubMed] [Google Scholar]
- Xiao L.; Hu Z. Y.; Dong X.; Tan Z.; Li W.; Tang M.; Chen L.; Yang L.; Tao Y.; Jiang Y.; Li J. Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy. Oncogene 2014, 33, 4568–4578. 10.1038/onc.2014.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reese T. A.; Tao L.; Lowe A.; Wang G.; Zarek C. M. A nuclear receptor involved in cholesterol metabolism regulates herpesvirus latency and reactivation. J. Immunol. 2018, 126–128. [Google Scholar]
- Ikeda M.; Longnecker R. Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability. Virology 2007, 360, 461–468. 10.1016/j.virol.2006.10.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Serquiña A. K. P.; Kambach D. M.; Sarker O.; Ziegelbauer J. M. Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection. mBio 2017, 8, 4249 10.1128/mBio.00576-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shin H.-J.; Park Y.-H.; Kim S.-U.; Moon H.-B.; Park D. S.; Han Y.-H.; et al. Hepatitis B virus X protein regulates hepatic glucose homeostasis via activation of inducible nitric oxide synthase. J. Biol. Chem. 2011, 286, 29872–29881. 10.1074/jbc.M111.259978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ivanova L.; Buch A.; Döhner K.; Pohlmann A.; Binz A.; Prank U.; et al. Conserved Tryptophan Motifs in the Large Tegument Protein pUL36 Are Required for Efficient Secondary Envelopment of Herpes Simplex Virus Capsids. J. Virol. 2016, 90, 5368–5383. 10.1128/JVI.03167-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Adams O.; Besken K.; Oberdörfer C.; MacKenzie C. R.; Takikawa O.; Däubener W. Role of indoleamine-2,3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J. Virol. 2004, 78, 2632–2636. 10.1128/JVI.78.5.2632-2636.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peng L.; Wu T.-T.; Tchieu J. H.; Feng J.; Brown H. J.; Feng J.; et al. Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency. J. Gen. Virol. 2010, 91, 463–469. 10.1099/vir.0.015073-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yu Y.; Maguire T. G.; Alwine J. C. Human cytomegalovirus infection induces adipocyte-like lipogenesis through activation of sterol regulatory element binding protein 1. J. Virol. 2012, 86, 2942–2949. 10.1128/JVI.06467-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Delgado T.; Sanchez E. L.; Camarda R.; Lagunoff M. Global Metabolic Profiling of Infection by an Oncogenic Virus: KSHV Induces and Requires Lipogenesis for Survival of Latent Infection. PLoS Pathog. 2012, 8, e1002866 10.1371/journal.ppat.1002866. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chambers J. W.; Maguire T. G.; Alwine J. C. Glutamine metabolism is essential for human cytomegalovirus infection. J. Virol. 2010, 84, 1867–1873. 10.1128/JVI.02123-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gazi I. F.; Elisaf M. S. Effect of infection on lipid profile: focus on Epstein–Barr virus. Clin. Lipidol. 2010, 5, 607–610. 10.2217/clp.10.53. [DOI] [Google Scholar]
- Heaton N. S.; Perera R.; Berger K. L.; Khadka S.; LaCount D. J.; Kuhn R. J.; et al. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 17345–17350. 10.1073/pnas.1010811107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greseth M. D.; Traktman P. De novo Fatty Acid Biosynthesis Contributes Significantly to Establishment of a Bioenergetically Favorable Environment for Vaccinia Virus Infection. PLoS Pathog. 2014, 10, e1004021 10.1371/journal.ppat.1004021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Teng C.-F.; Wu H.-C.; Hsieh W.-C.; Tsai H.-W.; Su I.-J. Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis. J. Virol. 2015, 89, 605–614. 10.1128/JVI.02363-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perlemuter G.; Sabile A.; Letteron P.; Vona G.; Topilco A.; Chrétien Y.; et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J. 2002, 16, 185–194. 10.1096/fj.01-0396com. [DOI] [PubMed] [Google Scholar]




